- Home
- GNFT vs NGNE Comparison
GNFT vs NGNE Comparison
Compare GNFT & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- NGNE
- Stock Information
- Founded
- GNFT 1999
- NGNE 2003
- Country
- GNFT France
- NGNE United States
- Employees
- GNFT N/A
- NGNE N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- GNFT Health Care
- NGNE Health Care
- Exchange
- GNFT Nasdaq
- NGNE Nasdaq
- Market Cap
- GNFT 202.6M
- NGNE 230.0M
- IPO Year
- GNFT 2019
- NGNE N/A
- Fundamental
- Price
- GNFT $3.83
- NGNE $17.36
- Analyst Decision
- GNFT Strong Buy
- NGNE Strong Buy
- Analyst Count
- GNFT 1
- NGNE 6
- Target Price
- GNFT $13.00
- NGNE $60.80
- AVG Volume (30 Days)
- GNFT 12.6K
- NGNE 274.4K
- Earning Date
- GNFT 04-03-2025
- NGNE 11-18-2024
- Dividend Yield
- GNFT N/A
- NGNE N/A
- EPS Growth
- GNFT N/A
- NGNE N/A
- EPS
- GNFT 0.47
- NGNE N/A
- Revenue
- GNFT $86,225,222.00
- NGNE $925,000.00
- Revenue This Year
- GNFT $145.20
- NGNE N/A
- Revenue Next Year
- GNFT N/A
- NGNE N/A
- P/E Ratio
- GNFT $7.98
- NGNE N/A
- Revenue Growth
- GNFT 175.45
- NGNE N/A
- 52 Week Low
- GNFT $3.35
- NGNE $14.42
- 52 Week High
- GNFT $6.42
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- GNFT 48.44
- NGNE 44.25
- Support Level
- GNFT $3.69
- NGNE $16.72
- Resistance Level
- GNFT $4.03
- NGNE $19.97
- Average True Range (ATR)
- GNFT 0.16
- NGNE 2.39
- MACD
- GNFT -0.00
- NGNE 0.08
- Stochastic Oscillator
- GNFT 24.59
- NGNE 19.43
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.